137 related articles for article (PubMed ID: 24166573)
21. Persistence with treatment for Wilson disease: a retrospective study.
Masełbas W; Członkowska A; Litwin T; Niewada M
BMC Neurol; 2019 Nov; 19(1):278. PubMed ID: 31718567
[TBL] [Abstract][Full Text] [Related]
22. [Wilson disease: an update].
Seo JK
Korean J Hepatol; 2006 Sep; 12(3):333-63. PubMed ID: 16998287
[TBL] [Abstract][Full Text] [Related]
23. Compliant treatment with anti-copper agents prevents clinically overt Wilson's disease in pre-symptomatic patients.
Dzieżyc K; Karliński M; Litwin T; Członkowska A
Eur J Neurol; 2014 Feb; 21(2):332-7. PubMed ID: 24313946
[TBL] [Abstract][Full Text] [Related]
24. [Therapy of Wilson disease].
Smolarek C; Stremmel W
Z Gastroenterol; 1999 Apr; 37(4):293-300. PubMed ID: 10378366
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy outcome after chelation therapy in Wilson disease. Evaluation of the German Embryotox Database.
Dathe K; Beck E; Schaefer C
Reprod Toxicol; 2016 Oct; 65():39-45. PubMed ID: 27350316
[TBL] [Abstract][Full Text] [Related]
26. Myelopathy secondary to copper deficiency as a complication of treatment of Wilson's disease.
Lozano Herrero J; Muñoz Bertrán E; Ortega González I; Gómez Espín R; López Espín MI
Gastroenterol Hepatol; 2012 Dec; 35(10):704-7. PubMed ID: 22609346
[TBL] [Abstract][Full Text] [Related]
27. [Late-onset Wilsońs disease].
Campos Franco J; Domínguez Santalla MJ; Tomé Martínez de Rituerto S; Otero Antón E; González Quintela A
An Med Interna; 2003 Aug; 20(8):416-8. PubMed ID: 14516263
[TBL] [Abstract][Full Text] [Related]
28. Patient with late-onset Wilson's disease: deterioration with penicillamine.
Sohtaoglu M; Ergin H; Ozekmekçi S; Gökdemir S; Sonsuz A; Arici C
Mov Disord; 2007 Jan; 22(2):290-1. PubMed ID: 17083099
[No Abstract] [Full Text] [Related]
29. Acute dystonia with thalamic and brainstem lesions after initial penicillamine treatment in Wilson's disease.
Huang CC; Chu NS
Eur Neurol; 1998; 39(1):32-7. PubMed ID: 9476721
[TBL] [Abstract][Full Text] [Related]
30. Penicillamine-induced lethal status dystonicus in a patient with Wilson's disease.
Svetel M; Sternić N; Pejović S; Kostić VS
Mov Disord; 2001 May; 16(3):568-9. PubMed ID: 11391761
[TBL] [Abstract][Full Text] [Related]
31. Early Onset of Wilson Disease: Diagnostic Challenges.
Wiernicka A; Dądalski M; Jańczyk W; Kamińska D; Naorniakowska M; Hüsing-Kabar A; Schmidt H; Socha P
J Pediatr Gastroenterol Nutr; 2017 Nov; 65(5):555-560. PubMed ID: 28753182
[TBL] [Abstract][Full Text] [Related]
32. Wilson disease.
El-Youssef M
Mayo Clin Proc; 2003 Sep; 78(9):1126-36. PubMed ID: 12962167
[TBL] [Abstract][Full Text] [Related]
33. Wilson disease in pregnancy: A case series.
Xiong X; Wei H; Zhu Y; Zhou X; Zhao Z; Chen Q
Medicine (Baltimore); 2023 Feb; 102(7):e32968. PubMed ID: 36800617
[TBL] [Abstract][Full Text] [Related]
34. Liver transplantation: treatment of choice for hepatic and neurological manifestation of Wilson's disease.
Schumacher G; Platz KP; Mueller AR; Neuhaus R; Steinmüller T; Bechstein WO; Becker M; Luck W; Schuelke M; Neuhaus P
Clin Transplant; 1997 Jun; 11(3):217-24. PubMed ID: 9193846
[TBL] [Abstract][Full Text] [Related]
35. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers.
Santiago R; Gottrand F; Debray D; Bridoux L; Lachaux A; Morali A; Lapeyre D; Lamireau T
J Pediatr Gastroenterol Nutr; 2015 Dec; 61(6):613-8. PubMed ID: 26230903
[TBL] [Abstract][Full Text] [Related]
36. Resolution of cerebral white matter lesions following long-term penicillamine therapy for Wilson's disease: report of a case.
Huang CC; Chu NS
J Formos Med Assoc; 1992 Jun; 91(6):627-9. PubMed ID: 1358351
[TBL] [Abstract][Full Text] [Related]
37. Long-term outcome in Serbian patients with Wilson disease.
Svetel M; Pekmezović T; Petrović I; Tomić A; Kresojević N; Jesić R; Kazić S; Raicević R; Stefanović D; Delibasić N; Zivanović D; Dordević M; Kostić VS
Eur J Neurol; 2009 Jul; 16(7):852-7. PubMed ID: 19473354
[TBL] [Abstract][Full Text] [Related]
38. Metal element excretion in 24-h urine in patients with Wilson disease under treatment of D-penicillamine.
Huang L; Yu X; Zhang J; Liu X; Zhang Y; Jiao X; Yu X
Biol Trace Elem Res; 2012 May; 146(2):154-9. PubMed ID: 22076732
[TBL] [Abstract][Full Text] [Related]
39. Trientine-induced neurological deterioration in a patient with Wilson's disease.
Kim B; Chung SJ; Shin HW
J Clin Neurosci; 2013 Apr; 20(4):606-8. PubMed ID: 23274038
[TBL] [Abstract][Full Text] [Related]
40. Role of Oxidative Stress in the Worsening of Neurologic Wilson Disease Following Chelating Therapy.
Kalita J; Kumar V; Ranjan A; Misra UK
Neuromolecular Med; 2015 Dec; 17(4):364-72. PubMed ID: 26224517
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
